Antares Pharma (United States)

Antares Pharma (United States)

Open Access statistics for Antares Pharma (United States), United States, covering academic research published from 2000 to 2024.

Open Access statistics for Antares Pharma (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

57%


Total
Publications

77


Total Open
Publications

44


Total
Citations

1.6K


Open Access
Percentage

57%


Total
Publications

77


Total Open
Publications

44


Total
Citations

1.6K

Website

download

Breakdown

21% 19% 17% 43%

Publisher Open

21%

Both

19%

Other Platform Open

17%

Closed

43%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

00.511.522.533.544.555.566.57Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

23%OA Journal

OA Journal 23%

7

Hybrid 32%

10

No Guarantees 45%

14

Other Platform Open

Institution 54%

15

Domain 39%

11

Preprint 25%

7

Other Internet 25%

7

Public 7%

2

Other Platform Locations

Name

Platform Type

Publications

RePEc: Research Papers in Economics - RePEc
Preprint
14
PubMed Central
Domain
8
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
7
Le Centre pour la Communication Scientifique Directe - HAL - TYPE UNDEFINED
Other Internet
5
Université Libre de Bruxelles - Dépôt institutionnel de l'Université libre de Bruxelles
Institution
4
Europe PMC
Domain
4
Econstor
Domain
4
Le Centre pour la Communication Scientifique Directe - HAL - Inria
Institution
3
University of North Texas - University of North Texas Digital Library
Other Internet
2
Queen Margaret University - Queen Margaret University Publications Repository
Institution
2
1 / 3

Data updated 7 April 2025

Share

Share

Share